Work Here?
Overview
Biote focuses on hormone optimization using clinically validated medical approaches to identify and treat imbalances in hormone production. It uses lab testing and medical assessment to pinpoint hormone deficiencies or excesses, then prescribes personalized treatment plans—often including bio-identical hormone therapy and related regimens—under medical supervision to restore balanced hormone levels. Biote differentiates itself through its emphasis on translating extensive scientific insight (80+ years of research) into validated protocols and continuing medical oversight, rather than generic supplements. The company’s goal is to help patients achieve balanced hormone levels and improve health outcomes by delivering scientifically grounded, physician-guided hormone optimization.
About Biote
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Irving, Texas
Founded
2012
Get referred to Biote
See people who can refer or advise you
Simplify's Take
What believers are saying
- Biote resolved several legal matters in Q2 2026, reducing future SG&A drag.
- Komal Bajaj became Chief Medical Officer on June 1, 2026, strengthening clinical credibility.
- Asteria normalized inventory in August 2026, supporting second-half 2026 recovery and guidance rebound.
What critics are saying
- The January 2026 Asteria recall cut Q2 2026 revenue 9.5% and margin.
- Bret Christensen’s June 8, 2026 exit and Bob Peterson’s interim CEO role signal instability.
- Biote’s SEC 10-K flags regulatory pressure on compounded hormones and Nasdaq delisting risk.
What makes Biote unique
- Biote’s practitioner network and training model create sticky clinic relationships and repeat utilization.
- Asteria Health gives Biote proprietary pellet manufacturing control, despite the January 2026 recall.
- Biote pairs pellets with supplements, creating cross-sell revenue beyond procedures.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$300M
Above
Industry Average
Funded Over
0 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Paid Time Off
Stock Price
Company News
Hemingway Medical Spa Inc. partnered with Biote because they share its commitment to improving the quality of patients lives through a more natural and less pharmacologic approach.
Hampton Roads Orthopaedics and Sports Medicine has chosen Biote as its partner for hormone replacement therapy due to their proven track record and commitment to excellence.
Irving-based Biote Corp. announced that it will acquire Asteria Health, a privately held manufacturer of compounded bioidentical hormones, in a deal valued at $8.5 million.
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hor
biote Corp., a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.
Biote is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Biote
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Irving, Texas
Founded
2012
Biote is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today